对于未经治疗的大动脉反患者的死亡负担
Philippe Généreux1, Nicholas S Amoroso2, Vinod H Thourani3
1Department of Cardiovascular Medicine, Morristown Medical Center, Morristown, New Jersey, USA.
JACC. Advances
|September 19, 2024
概括
患有中度至重度大动脉反 (AR) 的患者面临更高的死亡风险. 心脏损伤标志物,包括左心室和左心房重塑,显著增加死亡率,即使在不严重的AR病例.
科学领域:
- 心脏病学 心脏病学
- 医学数据库 医学数据库
- 健康 结果 研究 研究 结果
背景情况:
- 大动脉反 (AR) 需要大动脉置换 (AVR) 在严重的情况下.
- 某些因素表明,在不接受AVR的不严重的AR患者中,死亡风险高.
研究的目的:
- 确定与不同程度的AR患者的死亡率相关的关键因素,这些患者未接受AVR治疗.
- 通过使用大型,当代的数据库,分析AR严重性范围内的死亡率与死亡率的关联.
主要方法:
- 来自美国27所机构的非识别现实世界数据集的分析.
- 利用自然语言处理从心声图报告中提取AR严重程度.
- 采用Cox多变量分析以基于AR严重程度和临床因素来建模死亡风险.
主要成果:
- 中度AR增加了1.26倍的死亡风险,严重AR增加了2.37倍.
- 左心室喷射分数≤55%,左心室扩张,左心房扩张,心房动和尿酸的升高是显著的死亡预测因素.
- 死亡风险随着这些风险因素的存在和组合而升级.
结论:
- 左心室和左心房重塑,以及其他心脏损伤标志物,与未经治疗的AR患者的显著死亡率有关,包括中度AR患者.
- 需要进行进一步的研究,以确定AVR是否对具有风险因素的不太严重的AR患者有益.
更多相关视频
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.3K
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
18.5K
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
